2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …
N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[引用][C] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
N Marx, M Federici, K Schütt… - European Heart …, 2023 - europepmc.org
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford… - European Heart …, 2023 - eledrisi.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford, E Di Angelantonio… - 2023 - zdrowie.bayer.com.pl
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford… - European Heart …, 2023 - nvtnet.nl
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford, E Di Angelantonio… - 2023 - sochicar.cl
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford, E Di Angelantonio… - 2023 - scholar.archive.org
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford… - European …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford, E Di Angelantonio… - 2023 - congress-med.ru
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[PDF][PDF] 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
RM Christodorescu, C Crawford, E Di Angelantonio… - 2023 - sochob.cl
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …